In HER2-positive breast cancer, the HER2 overexpression causes cellular signaling stress and increases DNA replication errors, resulting in mutations in the PIK3CA and AKT genes of the PI3K/AKT signaling pathway. This evidence concerns the gene ERBB2 and breast carcinoma.